NO973311L - Ikke-farmasöytisk polysakkaridkonjugat - Google Patents

Ikke-farmasöytisk polysakkaridkonjugat

Info

Publication number
NO973311L
NO973311L NO973311A NO973311A NO973311L NO 973311 L NO973311 L NO 973311L NO 973311 A NO973311 A NO 973311A NO 973311 A NO973311 A NO 973311A NO 973311 L NO973311 L NO 973311L
Authority
NO
Norway
Prior art keywords
polysaccharide conjugate
pharmaceutical
pharmaceutical polysaccharide
conjugate
polysaccharide
Prior art date
Application number
NO973311A
Other languages
English (en)
Other versions
NO973311D0 (no
NO307835B1 (no
Inventor
Harold J Jennings
Francis Michon
Original Assignee
Ca Nat Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO973311L publication Critical patent/NO973311L/no
Application filed by Ca Nat Research Council filed Critical Ca Nat Research Council
Publication of NO973311D0 publication Critical patent/NO973311D0/no
Publication of NO307835B1 publication Critical patent/NO307835B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO973311A 1989-12-14 1997-07-17 Ikke-farmasøytisk polysakkaridkonjugat NO307835B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44819589A 1989-12-14 1989-12-14
PCT/CA1990/000437 WO1991008772A1 (en) 1989-12-14 1990-12-13 Improved meningococcal polysaccharide conjugate vaccine

Publications (3)

Publication Number Publication Date
NO973311L true NO973311L (no) 1992-08-14
NO973311D0 NO973311D0 (no) 1997-07-17
NO307835B1 NO307835B1 (no) 2000-06-05

Family

ID=23779371

Family Applications (2)

Application Number Title Priority Date Filing Date
NO922316A NO305275B1 (no) 1989-12-14 1992-06-12 FremgangsmÕte ved fremstilling av modifisert gruppe B polysakkarid fra Neisseria meningitidis eller modifisert E.coli K1 kapsulµrt polysakkarid
NO973311A NO307835B1 (no) 1989-12-14 1997-07-17 Ikke-farmasøytisk polysakkaridkonjugat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO922316A NO305275B1 (no) 1989-12-14 1992-06-12 FremgangsmÕte ved fremstilling av modifisert gruppe B polysakkarid fra Neisseria meningitidis eller modifisert E.coli K1 kapsulµrt polysakkarid

Country Status (30)

Country Link
US (3) US5576002A (no)
EP (1) EP0504202B1 (no)
JP (1) JP2637845B2 (no)
KR (1) KR0158436B1 (no)
CN (4) CN1049223C (no)
AR (1) AR243934A1 (no)
AT (1) ATE121947T1 (no)
AU (1) AU641715B2 (no)
BR (1) BR9007917A (no)
CA (1) CA2071811C (no)
CZ (1) CZ283530B6 (no)
DE (1) DE69019164T2 (no)
DK (1) DK0504202T3 (no)
ES (1) ES2071288T3 (no)
FI (2) FI104539B (no)
HR (1) HRP920872A2 (no)
HU (2) HU218146B (no)
IE (1) IE68414B1 (no)
IL (1) IL96676A (no)
IN (1) IN171747B (no)
NO (2) NO305275B1 (no)
NZ (1) NZ236471A (no)
PH (1) PH30305A (no)
PL (2) PL166035B1 (no)
RO (1) RO111416B1 (no)
RU (1) RU2105568C1 (no)
SI (1) SI20008B (no)
WO (1) WO1991008772A1 (no)
YU (1) YU24391A (no)
ZA (1) ZA9010065B (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
EP0504202B1 (en) * 1989-12-14 1995-05-03 National Research Council Of Canada Improved meningococcal polysaccharide conjugate vaccine
KR100293017B1 (ko) * 1992-09-24 2001-09-17 루시에 라포인테-쇼우, 카르타 커티 케이 그룹b스트렙토코쿠스ii형및v형다당류-단백질결합백신
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US6153406A (en) * 1993-07-23 2000-11-28 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B
US5679654A (en) * 1994-09-02 1997-10-21 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
US5700787A (en) * 1994-09-02 1997-12-23 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
ATE400295T1 (de) * 1995-06-07 2008-07-15 Glaxosmithkline Biolog Sa Vakzine mit einem polysaccharide antigen- trägerprotein konjugat und freiem trägerprotein
US5811102A (en) 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
ZA97248B (en) * 1996-01-18 1997-07-18 Rohm & Haas Method for identifying and quantifying polymers utilizing immunoassay techniques
WO1998008874A1 (en) 1996-08-27 1998-03-05 Chiron Corporation Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
WO1998008543A1 (en) † 1996-08-27 1998-03-05 Chiron Corporation Neisseria meningitidis serogroup b glycoconjugates and methods of using the same
US6426074B1 (en) * 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine
JP2002506448A (ja) 1997-06-24 2002-02-26 カイロン コーポレイション 抗髄膜炎菌ワクチン組成物を使用して成体を免疫する方法
ATE421527T1 (de) 1997-08-27 2009-02-15 Novartis Vaccines & Diagnostic Molekular-mimetika von meningokokkus b epitopen
ES2346022T3 (es) 1997-12-23 2010-10-07 Baxter Healthcare S.A. Procedimiento para la extraccion y el aislamiento de polisacaridos capsulares bacterianos para su uso como vacunas o ligandos a proteinas como vacunas de conjugados.
DE69941574D1 (de) * 1998-08-19 2009-12-03 Baxter Healthcare Sa Immunogenes beta-propionamido-gebundenes polysaccharid-protein konjugat geeignet als impfstoff und hergestellt bei verwendung von n-acryloyliertem polysaccharid
US6436653B1 (en) 1998-12-15 2002-08-20 Exiqon A/S Method for introduction of reporter groups into bacterial lipopolysaccharide-derived carbohydrates and the subsequent coupling of such derivatives onto solid surfaces
US7083777B1 (en) * 1999-04-02 2006-08-01 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
US6518037B2 (en) * 1999-11-12 2003-02-11 University Of Iowa Research Foundation Two-component system that controls bacterial membrane synthesis
GB9928196D0 (en) * 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
SV2003000753A (es) 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
AU2002252638A1 (en) 2001-04-17 2002-10-28 Children's Hospital Oakland Research Institute Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
GB0121591D0 (en) * 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
DE60325565D1 (de) * 2002-03-26 2009-02-12 Novartis Vaccines & Diagnostic Modifizierte saccharide mit verbesserter stabilität in wasser
EP1638581A2 (en) * 2003-03-31 2006-03-29 The Brigham And Women's Hospital, Inc. Zwitterionic immunomodulators for the treatment of asthma and allergy
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
EP1654290B1 (en) 2003-08-12 2019-03-13 Lipoxen Technologies Limited Sialic acid derivatives for protein derivatisation and conjugation
KR20070060069A (ko) 2004-06-23 2007-06-12 칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 다당류 유도체 및 면역반응의 유도에서의 용도
US8148335B2 (en) 2004-06-23 2012-04-03 Children's Hospital & Research Center Oakland De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
GB0428394D0 (en) * 2004-12-24 2005-02-02 Chiron Srl Saccharide conjugate vaccines
PT1896065E (pt) 2005-06-27 2011-08-31 Glaxosmithkline Biolog Sa Processo para a preparação de vacinas
US8206726B2 (en) 2006-02-06 2012-06-26 The Brigham And Women's Hospital, Inc. Zwitterionic polysaccharides for promotion of immune system maturation and health
GB0611914D0 (en) 2006-06-15 2006-07-26 Teti Giuseppe Peptides that mimic non-human cross-reactive protective epitopes of the group Bmeningococcal capsulsar polysaccharide
EP1872791A1 (en) * 2006-06-30 2008-01-02 Institut Pasteur Use of bacterial polysaccharides for biofilm inhibition
AU2008265767B2 (en) * 2007-06-20 2014-11-13 Pfizer Ireland Pharmaceuticals Modified polysaccharides for conjugate vaccines
EP3067048B1 (en) 2007-12-07 2018-02-14 GlaxoSmithKline Biologicals SA Compositions for inducing immune responses
WO2010083477A2 (en) 2009-01-16 2010-07-22 University Of Maryland, Baltimore Broad spectrum vaccine against non-typhoidal salmonella
WO2013009945A1 (en) 2011-07-12 2013-01-17 The Brigham And Women's Hospital, Inc. Lipid-containing psa compositions, methods of isolation and methods of use thereof
EP2752403A1 (de) * 2013-01-08 2014-07-09 Sika Technology AG Amin für emissionsarme Epoxidharz-Produkte
WO2017031431A1 (en) 2015-08-19 2017-02-23 President And Fellows Of Harvard College Lipidated psa compositions and methods
EP3484441A4 (en) 2016-07-15 2020-03-18 President and Fellows of Harvard College GLYCOLIPID COMPOSITIONS AND METHODS OF USE
MX2019009011A (es) * 2017-01-31 2019-09-26 Pfizer Composiciones de neisseria meningitidis y metodos respectivos.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) * 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4619828A (en) * 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US4644059A (en) * 1982-07-06 1987-02-17 Connaught Laboratories, Inc. Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine
US4695624A (en) * 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4727136A (en) * 1985-10-01 1988-02-23 Canadian Patents And Development Ltd. Modified meningococcal group B polysaccharide for conjugate vaccine
EP0504202B1 (en) * 1989-12-14 1995-05-03 National Research Council Of Canada Improved meningococcal polysaccharide conjugate vaccine

Also Published As

Publication number Publication date
NO922316D0 (no) 1992-06-12
NO973311D0 (no) 1997-07-17
SI20008B (en) 2001-02-28
EP0504202B1 (en) 1995-05-03
HRP920872A2 (en) 1997-06-30
JPH05505392A (ja) 1993-08-12
DK0504202T3 (da) 1995-10-02
CN1100656A (zh) 1995-03-29
ATE121947T1 (de) 1995-05-15
US5902586A (en) 1999-05-11
IE68414B1 (en) 1996-06-12
AR243934A1 (es) 1993-09-30
YU24391A (sh) 1995-12-04
HUT64480A (en) 1994-01-28
WO1991008772A1 (en) 1991-06-27
IL96676A0 (en) 1991-09-16
IL96676A (en) 1996-09-12
NZ236471A (en) 1992-10-28
CZ628490A3 (en) 1997-12-17
PL166035B1 (pl) 1995-03-31
PH30305A (en) 1997-02-20
HU218146B (hu) 2000-06-28
NO922316L (no) 1992-08-14
KR0158436B1 (ko) 1998-12-01
NO307835B1 (no) 2000-06-05
RU2105568C1 (ru) 1998-02-27
ES2071288T3 (es) 1995-06-16
CN1049223C (zh) 2000-02-09
DE69019164D1 (de) 1995-06-08
SI20008A (sl) 2000-02-29
CN1036504C (zh) 1997-11-26
IE904513A1 (en) 1991-06-19
CN1100428A (zh) 1995-03-22
FI104539B (fi) 2000-02-29
CN1055541A (zh) 1991-10-23
US5683699A (en) 1997-11-04
CN1072506C (zh) 2001-10-10
CN1036522C (zh) 1997-11-26
FI19991917A (fi) 1999-09-09
NO305275B1 (no) 1999-05-03
DE69019164T2 (de) 1995-09-07
IN171747B (no) 1992-12-26
CA2071811C (en) 2003-11-04
HU9201966D0 (en) 1992-10-28
JP2637845B2 (ja) 1997-08-06
PL166659B1 (pl) 1995-06-30
AU641715B2 (en) 1993-09-30
ZA9010065B (en) 1992-02-26
EP0504202A1 (en) 1992-09-23
CN1096516A (zh) 1994-12-21
AU6898791A (en) 1991-07-18
PL288271A1 (en) 1991-12-16
FI922737A0 (fi) 1992-06-12
RO111416B1 (ro) 1996-10-31
BR9007917A (pt) 1992-10-20
CA2071811A1 (en) 1991-06-15
CZ283530B6 (cs) 1998-04-15
US5576002A (en) 1996-11-19

Similar Documents

Publication Publication Date Title
NO973311D0 (no) Ikke-farmasöytisk polysakkaridkonjugat
DE69033087D1 (de) Verbesserte Glykopeptid-Derivative
NO922005D0 (no) Farmasoeytiske preparater
BR8906392A (pt) Conexao
IT1237977B (it) Snodo girevole omocinetico
BG91785A (bg) Лекарствена форма
DK0385610T3 (da) Konjugater
DE68906762D1 (de) Prostaglandin-polysaccharid-konjugat.
FR2646493B1 (fr) Centreur de tubage
NO902279D0 (no) Benzocykloalkanderivater og fremstilling derav.
IT9020680A0 (it) snodo doppio
FR2650644B1 (fr) Joint homocinetique
DK80890A (da) Thien-triazol-diazepin-derivater
IT8922340A0 (it) Preservativo
FR2645395B1 (fr) Charrue multisocs reglable
IT1245851B (it) 13-desosso-4'-desossi-4'-iodoantracicline
IT9019928A0 (it) Giunto
NO901052D0 (no) 1h-pyrazol-1-acetamider og fremstilling derav.
DE59009626D1 (de) Basische Polysaccharide.
DK408189D0 (da) Farmaceutisk praeparat
FR2649773B1 (fr) Joint imperdable
DK207590D0 (da) Farmaceutisk praeparat
DK204190D0 (da) Farmaceutisk praeparat
SE8904394D0 (sv) Handeldvapen
LV5735B4 (lv) Medikamenti